+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aptamers Market by Type (Nucleic Acid Aptamers, Peptide Aptamers), Technology (Non-SELEX-Based Technologies, SELEX Technology), Application, End-User - Global Forecast 2025-2030- Product Image
Aptamers Market by Type (Nucleic Acid Aptamers, Peptide Aptamers), Technology (Non-SELEX-Based Technologies, SELEX Technology), Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Aptamers Market by Type (Nucleic Acid Aptamers, Peptide Aptamers), Technology (Non-SELEX-Based Technologies, SELEX Technology), Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904654
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Aptamers Market is at a pivotal stage, attracting significant attention from stakeholders across diagnostics, therapeutics, and life sciences. Senior decision-makers are prioritizing solutions that enhance precision, enable cost containment, and accelerate innovation across research and commercial environments.

Market Snapshot: Aptamers Market Growth and Outlook

The Aptamers Market grew from USD 254.35 million in 2024 to USD 285.51 million in 2025. It is expected to continue growing at a CAGR of 12.43%, reaching USD 513.77 million by 2030. This positive market trajectory is being fueled by rapid adoption of aptamer technologies in molecular diagnostics, emerging therapeutic modalities, and environmental monitoring applications.

Scope & Segmentation of the Aptamers Market

  • Molecular Types: Nucleic acid aptamers—including DNA and RNA variants—and peptide aptamers are deployed across applications, each chosen based on binding affinity, specificity, and suitability for in-vivo or in-vitro use.
  • Technology Platforms: SELEX-based methodologies (such as capillary electrophoresis, cell-SELEX, microfluidic, and graphene oxide SELEX) and non-SELEX discovery platforms are integrated to support efficient aptamer selection, higher-throughput screening, and customized molecular engineering.
  • Applications: Utilization spans clinical diagnostics for disease markers (including oncology, metabolic, cardiovascular, genetic, and neurological conditions), food and environmental safety (such as agricultural product testing and contaminant monitoring), as well as therapeutics and drug development targeting a range of chronic and rare diseases.
  • End-Users: Key sectors include academic and research institutions, hospitals and clinics, and pharmaceutical or biotechnology companies, each driving investment priorities through research, implementation, and commercialization.
  • Regional Coverage: Geographic analysis extends across the Americas, Europe, the Middle East, Africa, and Asia-Pacific, with deep dives into sub-regional hubs—such as the United States, China, India, Japan, UK, Germany, and Brazil.
  • Key Market Participants: The landscape features diversified players including 2bind GmbH, Agilent Technologies, Aptagen LLC, Aptamer Group PLC, SomaLogic Inc., NeoVentures Biotechnology, AptaTargets SL, and Base Pair Biotechnologies, among many others contributing to technical advancement and broader adoption.

Key Takeaways for Senior Decision-Makers

  • Integration of aptamers is accelerating the shift toward personalized medicine, allowing tailored diagnostic and targeted therapeutic approaches based on molecular specificity.
  • Technological innovations—such as the use of microfluidic SELEX and computational modeling—are enabling faster, more scalable aptamer discovery and optimization.
  • Cross-disciplinary collaborations between research institutions and commercial partners are streamlining development of new diagnostic kits and therapeutic candidates by sharing expertise and infrastructure.
  • Growing focus on regional manufacturing and diversified supply chains helps stakeholders mitigate risks related to supply disruptions and regulatory changes.
  • The market is witnessing a rise in end-to-end service offerings, enabling organizations to access custom design, analytic reporting, and regulatory-compliant quality controls with greater efficiency.

Tariff Impact on Aptamer Supply Chains

Recent United States import duties on laboratory reagents and core chemical inputs have elevated cost pressures for both developers and manufacturers. Organizations are responding by diversifying supplier bases, exploring domestic manufacturing options, and implementing cost-optimization measures within procurement and production workflows. This evolving environment is leading to increased attention on supply chain transparency, risk mitigation strategies, and collaborative consortia to ensure continued innovation amid market constraints.

Methodology & Data Sources

This market analysis is grounded in a thorough combination of primary and secondary sources. Peer-reviewed literature, patent databases, and industry financial disclosures were synthesized alongside expert interviews and workshops. Comprehensive supply chain mapping and trend validation exercises support the accuracy and relevance of insights.

Why This Report Matters

  • Enables executive teams to assess the evolving aptamer landscape and refine investment decisions in diagnostics and therapeutics.
  • Supports supply chain leaders in responding proactively to global cost changes, ensuring operational continuity and risk-adjusted sourcing strategies.
  • Delivers actionable insights on segmentation and innovation trends crucial for product strategy, regulatory compliance, and market expansion.

Conclusion

This report provides a clear roadmap for leveraging aptamer technologies to drive improved diagnostic, therapeutic, and operational outcomes. Informed decision-making will enable stakeholders to navigate complexity and maximize market potential in this evolving field.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence and high-throughput screening to streamline aptamer selection processes
5.2. Emergence of pegylated and chemically modified aptamers to enhance in vivo stability and bioavailability
5.3. Expansion of aptamer-based point-of-care diagnostic platforms for rapid pathogen detection in clinical settings
5.4. Rising investment in cell-SELEX technologies to discover next-generation aptamers for rare disease targets
5.5. Increasing collaboration between academic institutes and biotech firms to accelerate aptamer commercialization
5.6. Adoption of microfluidics and automation to reduce turnaround time in aptamer screening workflows
5.7. Development of multivalent aptamer conjugates for targeted drug delivery in oncology and personalized medicine
5.8. Growth of aptamer-nanoparticle hybrid platforms for ultrasensitive biomarker detection and imaging applications
5.9. Regulatory advancements enabling faster approval pathways for aptamer therapeutics and diagnostic assays
5.10. Focus on triple helix and G-quadruplex aptamer structures to improve binding affinity and specificity
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Aptamers Market, by Type
8.1. Introduction
8.2. Nucleic Acid Aptamers
8.2.1. DNA Aptamers
8.2.2. RNA Aptamers
8.3. Peptide Aptamers
9. Aptamers Market, by Technology
9.1. Introduction
9.2. Non-SELEX-Based Technologies
9.3. SELEX Technology
9.3.1. Capillary Electrophoresis (CE)-SELEX
9.3.2. Capture-SELEX
9.3.3. Cell-SELEX
9.3.4. Graphene Oxide (GO)-SELEX
9.3.5. Microfluidic SELEX
9.3.6. Standard SELEX
10. Aptamers Market, by Application
10.1. Introduction
10.2. Clinical Diagnostics
10.2.1. Cardiovascular & Metabolic Disease Diagnostics
10.2.2. Genetic & Rare Disease Screening
10.2.3. Infectious Disease Diagnostics
10.2.4. Neurological Disorder Diagnostics
10.2.5. Oncology Diagnostics
10.3. Food & Environmental Safety
10.3.1. Agricultural Testing
10.3.2. Environmental Monitoring
10.3.3. Food Safety Testing
10.4. Therapeutics & Drug Development
10.4.1. Cardiovascular Diseases
10.4.2. Infectious Diseases
10.4.3. Neurological Disorders
10.4.4. Oncology
10.4.5. Rare & Genetic Disorders
11. Aptamers Market, by End-User
11.1. Introduction
11.2. Academic & Research Institutions
11.3. Hospital & Clinics
11.4. Pharmaceutical & Biotechnology Companies
12. Americas Aptamers Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Aptamers Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Aptamers Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. 2bind GmbH
15.3.2. Agilent Technologies, Inc.
15.3.3. Aptadel Therapeutics SL
15.3.4. Aptagen, LLC
15.3.5. AptaMatrix, Inc.
15.3.6. Aptamer Group PLC
15.3.7. AptaTargets SL
15.3.8. AptusBiotech
15.3.9. Astellas Pharma Inc.
15.3.10. Base Pair Biotechnologies, Inc.
15.3.11. Basking Biosciences
15.3.12. Bio-Techne Corporation
15.3.13. Biogenes Technologies Sdn. Bhd.
15.3.14. Biotage
15.3.15. Cage Bio, Inc.
15.3.16. Creative Biogene
15.3.17. Creative Biolabs
15.3.18. Drive Therapeutics, LLC
15.3.19. F. Hoffmann-La Roche AG
15.3.20. Kaneka Eurogentec S.A.
15.3.21. NEC Corporation
15.3.22. NeoVentures Biotechnology Inc.
15.3.23. NOVAPTECH, S.A.S.
15.3.24. Profacgen
15.3.25. SomaLogic, Inc.
15.3.26. TAGCyx Biotechnologies, Inc.
15.3.27. Veraptus
15.3.28. Vivonics Inc.
15.3.29. Zentek Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. APTAMERS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL APTAMERS MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 3. GLOBAL APTAMERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 4. GLOBAL APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 5. GLOBAL APTAMERS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL APTAMERS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 7. GLOBAL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 9. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 11. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 13. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 15. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 19. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 21. APTAMERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. APTAMERS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. APTAMERS MARKET: RESEARCHAI
FIGURE 24. APTAMERS MARKET: RESEARCHSTATISTICS
FIGURE 25. APTAMERS MARKET: RESEARCHCONTACTS
FIGURE 26. APTAMERS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. APTAMERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL APTAMERS MARKET SIZE, 2018-2024 (USD THOUSAND)
TABLE 4. GLOBAL APTAMERS MARKET SIZE, 2025-2030 (USD THOUSAND)
TABLE 5. GLOBAL APTAMERS MARKET SIZE, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 6. GLOBAL APTAMERS MARKET SIZE, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 7. GLOBAL APTAMERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD THOUSAND)
TABLE 8. GLOBAL APTAMERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD THOUSAND)
TABLE 9. GLOBAL APTAMERS MARKET SIZE, BY TYPE, 2018-2024 (USD THOUSAND)
TABLE 10. GLOBAL APTAMERS MARKET SIZE, BY TYPE, 2025-2030 (USD THOUSAND)
TABLE 11. GLOBAL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 12. GLOBAL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 13. GLOBAL APTAMERS MARKET SIZE, BY DNA APTAMERS, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 14. GLOBAL APTAMERS MARKET SIZE, BY DNA APTAMERS, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 15. GLOBAL APTAMERS MARKET SIZE, BY RNA APTAMERS, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 16. GLOBAL APTAMERS MARKET SIZE, BY RNA APTAMERS, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 17. GLOBAL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2024 (USD THOUSAND)
TABLE 18. GLOBAL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2025-2030 (USD THOUSAND)
TABLE 19. GLOBAL APTAMERS MARKET SIZE, BY PEPTIDE APTAMERS, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 20. GLOBAL APTAMERS MARKET SIZE, BY PEPTIDE APTAMERS, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 21. GLOBAL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 22. GLOBAL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 23. GLOBAL APTAMERS MARKET SIZE, BY NON-SELEX-BASED TECHNOLOGIES, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 24. GLOBAL APTAMERS MARKET SIZE, BY NON-SELEX-BASED TECHNOLOGIES, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 25. GLOBAL APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 26. GLOBAL APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 27. GLOBAL APTAMERS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS (CE)-SELEX, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 28. GLOBAL APTAMERS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS (CE)-SELEX, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 29. GLOBAL APTAMERS MARKET SIZE, BY CAPTURE-SELEX, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 30. GLOBAL APTAMERS MARKET SIZE, BY CAPTURE-SELEX, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 31. GLOBAL APTAMERS MARKET SIZE, BY CELL-SELEX, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 32. GLOBAL APTAMERS MARKET SIZE, BY CELL-SELEX, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 33. GLOBAL APTAMERS MARKET SIZE, BY GRAPHENE OXIDE (GO)-SELEX, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 34. GLOBAL APTAMERS MARKET SIZE, BY GRAPHENE OXIDE (GO)-SELEX, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 35. GLOBAL APTAMERS MARKET SIZE, BY MICROFLUIDIC SELEX, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 36. GLOBAL APTAMERS MARKET SIZE, BY MICROFLUIDIC SELEX, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 37. GLOBAL APTAMERS MARKET SIZE, BY STANDARD SELEX, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 38. GLOBAL APTAMERS MARKET SIZE, BY STANDARD SELEX, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 39. GLOBAL APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 40. GLOBAL APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 41. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD THOUSAND)
TABLE 42. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD THOUSAND)
TABLE 43. GLOBAL APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 44. GLOBAL APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 45. GLOBAL APTAMERS MARKET SIZE, BY CARDIOVASCULAR & METABOLIC DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 46. GLOBAL APTAMERS MARKET SIZE, BY CARDIOVASCULAR & METABOLIC DISEASE DIAGNOSTICS, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 47. GLOBAL APTAMERS MARKET SIZE, BY GENETIC & RARE DISEASE SCREENING, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 48. GLOBAL APTAMERS MARKET SIZE, BY GENETIC & RARE DISEASE SCREENING, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 49. GLOBAL APTAMERS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 50. GLOBAL APTAMERS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 51. GLOBAL APTAMERS MARKET SIZE, BY NEUROLOGICAL DISORDER DIAGNOSTICS, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 52. GLOBAL APTAMERS MARKET SIZE, BY NEUROLOGICAL DISORDER DIAGNOSTICS, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 53. GLOBAL APTAMERS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 54. GLOBAL APTAMERS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 55. GLOBAL APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD THOUSAND)
TABLE 56. GLOBAL APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD THOUSAND)
TABLE 57. GLOBAL APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 58. GLOBAL APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 59. GLOBAL APTAMERS MARKET SIZE, BY AGRICULTURAL TESTING, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 60. GLOBAL APTAMERS MARKET SIZE, BY AGRICULTURAL TESTING, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 61. GLOBAL APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 62. GLOBAL APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 63. GLOBAL APTAMERS MARKET SIZE, BY FOOD SAFETY TESTING, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 64. GLOBAL APTAMERS MARKET SIZE, BY FOOD SAFETY TESTING, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 65. GLOBAL APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2024 (USD THOUSAND)
TABLE 66. GLOBAL APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2025-2030 (USD THOUSAND)
TABLE 67. GLOBAL APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 68. GLOBAL APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 69. GLOBAL APTAMERS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 70. GLOBAL APTAMERS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 71. GLOBAL APTAMERS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 72. GLOBAL APTAMERS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 73. GLOBAL APTAMERS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 74. GLOBAL APTAMERS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 75. GLOBAL APTAMERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 76. GLOBAL APTAMERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 77. GLOBAL APTAMERS MARKET SIZE, BY RARE & GENETIC DISORDERS, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 78. GLOBAL APTAMERS MARKET SIZE, BY RARE & GENETIC DISORDERS, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 79. GLOBAL APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2024 (USD THOUSAND)
TABLE 80. GLOBAL APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2025-2030 (USD THOUSAND)
TABLE 81. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2018-2024 (USD THOUSAND)
TABLE 82. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2025-2030 (USD THOUSAND)
TABLE 83. GLOBAL APTAMERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 84. GLOBAL APTAMERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 85. GLOBAL APTAMERS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 86. GLOBAL APTAMERS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 87. GLOBAL APTAMERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD THOUSAND)
TABLE 88. GLOBAL APTAMERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD THOUSAND)
TABLE 89. AMERICAS APTAMERS MARKET SIZE, BY TYPE, 2018-2024 (USD THOUSAND)
TABLE 90. AMERICAS APTAMERS MARKET SIZE, BY TYPE, 2025-2030 (USD THOUSAND)
TABLE 91. AMERICAS APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2024 (USD THOUSAND)
TABLE 92. AMERICAS APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2025-2030 (USD THOUSAND)
TABLE 93. AMERICAS APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 94. AMERICAS APTAMERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 95. AMERICAS APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 96. AMERICAS APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 97. AMERICAS APTAMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD THOUSAND)
TABLE 98. AMERICAS APTAMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD THOUSAND)
TABLE 99. AMERICAS APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD THOUSAND)
TABLE 100. AMERICAS APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD THOUSAND)
TABLE 101. AMERICAS APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2024 (USD THOUSAND)
TABLE 102. AMERICAS APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2025-2030 (USD THOUSAND)
TABLE 103. AMERICAS APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2024 (USD THOUSAND)
TABLE 104. AMERICAS APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2025-2030 (USD THOUSAND)
TABLE 105. AMERICAS APTAMERS MARKET SIZE, BY END-USER, 2018-2024 (USD THOUSAND)
TABLE 106. AMERICAS APTAMERS MARKET SIZE, BY END-USER, 2025-2030 (USD THOUSAND)
TABLE 107. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD THOUSAND)
TABLE 108. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD THOUSAND)
TABLE 109. UNITED STATES APTAMERS MARKET SIZE, BY TYPE, 2018-2024 (USD THOUSAND)
TABLE 110. UNITED STATES APTAMERS MARKET SIZE, BY TYPE, 2025-2030 (USD THOUSAND)
TABLE 111. UNITED STATES APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2024 (USD THOUSAND)
TABLE 112. UNITED STATES APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2025-2030 (USD THOUSAND)
TABLE 113. UNITED STATES APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 114. UNITED STATES APTAMERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 115. UNITED STATES APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 116. UNITED STATES APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 117. UNITED STATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD THOUSAND)
TABLE 118. UNITED STATES APTAMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD THOUSAND)
TABLE 119. UNITED STATES APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD THOUSAND)
TABLE 120. UNITED STATES APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD THOUSAND)
TABLE 121. UNITED STATES APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2024 (USD THOUSAND)
TABLE 122. UNITED STATES APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2025-2030 (USD THOUSAND)
TABLE 123. UNITED STATES APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2024 (USD THOUSAND)
TABLE 124. UNITED STATES APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2025-2030 (USD THOUSAND)
TABLE 125. UNITED STATES APTAMERS MARKET SIZE, BY END-USER, 2018-2024 (USD THOUSAND)
TABLE 126. UNITED STATES APTAMERS MARKET SIZE, BY END-USER, 2025-2030 (USD THOUSAND)
TABLE 127. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2018-2024 (USD THOUSAND)
TABLE 128. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2025-2030 (USD THOUSAND)
TABLE 129. CANADA APTAMERS MARKET SIZE, BY TYPE, 2018-2024 (USD THOUSAND)
TABLE 130. CANADA APTAMERS MARKET SIZE, BY TYPE, 2025-2030 (USD THOUSAND)
TABLE 131. CANADA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2024 (USD THOUSAND)
TABLE 132. CANADA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2025-2030 (USD THOUSAND)
TABLE 133. CANADA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 134. CANADA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 135. CANADA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 136. CANADA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 137. CANADA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD THOUSAND)
TABLE 138. CANADA APTAMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD THOUSAND)
TABLE 139. CANADA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD THOUSAND)
TABLE 140. CANADA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD THOUSAND)
TABLE 141. CANADA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2024 (USD THOUSAND)
TABLE 142. CANADA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2025-2030 (USD THOUSAND)
TABLE 143. CANADA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2024 (USD THOUSAND)
TABLE 144. CANADA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2025-2030 (USD THOUSAND)
TABLE 145. CANADA APTAMERS MARKET SIZE, BY END-USER, 2018-2024 (USD THOUSAND)
TABLE 146. CANADA APTAMERS MARKET SIZE, BY END-USER, 2025-2030 (USD THOUSAND)
TABLE 147. MEXICO APTAMERS MARKET SIZE, BY TYPE, 2018-2024 (USD THOUSAND)
TABLE 148. MEXICO APTAMERS MARKET SIZE, BY TYPE, 2025-2030 (USD THOUSAND)
TABLE 149. MEXICO APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2024 (USD THOUSAND)
TABLE 150. MEXICO APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2025-2030 (USD THOUSAND)
TABLE 151. MEXICO APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 152. MEXICO APTAMERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 153. MEXICO APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 154. MEXICO APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 155. MEXICO APTAMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD THOUSAND)
TABLE 156. MEXICO APTAMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD THOUSAND)
TABLE 157. MEXICO APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD THOUSAND)
TABLE 158. MEXICO APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD THOUSAND)
TABLE 159. MEXICO APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2024 (USD THOUSAND)
TABLE 160. MEXICO APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2025-2030 (USD THOUSAND)
TABLE 161. MEXICO APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2024 (USD THOUSAND)
TABLE 162. MEXICO APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2025-2030 (USD THOUSAND)
TABLE 163. MEXICO APTAMERS MARKET SIZE, BY END-USER, 2018-2024 (USD THOUSAND)
TABLE 164. MEXICO APTAMERS MARKET SIZE, BY END-USER, 2025-2030 (USD THOUSAND)
TABLE 165. BRAZIL APTAMERS MARKET SIZE, BY TYPE, 2018-2024 (USD THOUSAND)
TABLE 166. BRAZIL APTAMERS MARKET SIZE, BY TYPE, 2025-2030 (USD THOUSAND)
TABLE 167. BRAZIL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2024 (USD THOUSAND)
TABLE 168. BRAZIL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2025-2030 (USD THOUSAND)
TABLE 169. BRAZIL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 170. BRAZIL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 171. BRAZIL APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 172. BRAZIL APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 173. BRAZIL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD THOUSAND)
TABLE 174. BRAZIL APTAMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD THOUSAND)
TABLE 175. BRAZIL APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD THOUSAND)
TABLE 176. BRAZIL APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD THOUSAND)
TABLE 177. BRAZIL APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2024 (USD THOUSAND)
TABLE 178. BRAZIL APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2025-2030 (USD THOUSAND)
TABLE 179. BRAZIL APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2024 (USD THOUSAND)
TABLE 180. BRAZIL APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2025-2030 (USD THOUSAND)
TABLE 181. BRAZIL APTAMERS MARKET SIZE, BY END-USER, 2018-2024 (USD THOUSAND)
TABLE 182. BRAZIL APTAMERS MARKET SIZE, BY END-USER, 2025-2030 (USD THOUSAND)
TABLE 183. ARGENTINA APTAMERS MARKET SIZE, BY TYPE, 2018-2024 (USD THOUSAND)
TABLE 184. ARGENTINA APTAMERS MARKET SIZE, BY TYPE, 2025-2030 (USD THOUSAND)
TABLE 185. ARGENTINA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2024 (USD THOUSAND)
TABLE 186. ARGENTINA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2025-2030 (USD THOUSAND)
TABLE 187. ARGENTINA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 188. ARGENTINA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 189. ARGENTINA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 190. ARGENTINA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 191. ARGENTINA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD THOUSAND)
TABLE 192. ARGENTINA APTAMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD THOUSAND)
TABLE 193. ARGENTINA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD THOUSAND)
TABLE 194. ARGENTINA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD THOUSAND)
TABLE 195. ARGENTINA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2024 (USD THOUSAND)
TABLE 196. ARGENTINA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2025-2030 (USD THOUSAND)
TABLE 197. ARGENTINA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2024 (USD THOUSAND)
TABLE 198. ARGENTINA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2025-2030 (USD THOUSAND)
TABLE 199. ARGENTINA APTAMERS MARKET SIZE, BY END-USER, 2018-2024 (USD THOUSAND)
TABLE 200. ARGENTINA APTAMERS MARKET SIZE, BY END-USER, 2025-2030 (USD THOUSAND)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY TYPE, 2018-2024 (USD THOUSAND)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY TYPE, 2025-2030 (USD THOUSAND)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2024 (USD THOUSAND)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2025-2030 (USD THOUSAND)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD THOUSAND)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD THOUSAND)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD THOUSAND)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD THOUSAND)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2024 (USD THOUSAND)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2025-2030 (USD THOUSAND)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2024 (USD THOUSAND)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2025-2030 (USD THOUSAND)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY END-USER, 2018-2024 (USD THOUSAND)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY END-USER, 2025-2030 (USD THOUSAND)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD THOUSAND)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD THOUSAND)
TABLE 221. UNITED KINGDOM APTAMERS MARKET SIZE, BY TYPE, 2018-2024 (USD THOUSAND)
TABLE 222. UNITED KINGDOM APTAMERS MARKET SIZE, BY TYPE, 2025-2030 (USD THOUSAND)
TABLE 223. UNITED KINGDOM APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2024 (USD THOUSAND)
TABLE 224. UNITED KINGDOM APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2025-2030 (USD THOUSAND)
TABLE 225. UNITED KINGDOM APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 226. UNITED KINGDOM APTAMERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 227. UNITED KINGDOM APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 228. UNITED KINGDOM APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 229. UNITED KINGDOM APTAMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD THOUSAND)
TABLE 230. UNITED KINGDOM APTAMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD THOUSAND)
TABLE 231. UNITED KINGDOM APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD THOUSAND)
TABLE 232. UNITED KINGDOM APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD THOUSAND)
TABLE 233. UNITED KINGDOM APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2024 (USD THOUSAND)
TABLE 234. UNITED KINGDOM APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2025-2030 (USD THOUSAND)
TABLE 235. UNITED KINGDOM APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2024 (USD THOUSAND)
TABLE 236. UNITED KINGDOM APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2025-2030 (USD THOUSAND)
TABLE 237. UNITED KINGDOM APTAMERS MARKET SIZE, BY END-USER, 2018-2024 (USD THOUSAND)
TABLE 238. UNITED KINGDOM APTAMERS MARKET SIZE, BY END-USER, 2025-2030 (USD THOUSAND)
TABLE 239. GERMANY APTAMERS MARKET SIZE, BY TYPE, 2018-2024 (USD THOUSAND)
TABLE 240. GERMANY APTAMERS MARKET SIZE, BY TYPE, 2025-2030 (USD THOUSAND)
TABLE 241. GERMANY APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2024 (USD THOUSAND)
TABLE 242. GERMANY APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2025-2030 (USD THOUSAND)
TABLE 243. GERMANY APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 244. GERMANY APTAMERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 245. GERMANY APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 246. GERMANY APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 247. GERMANY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD THOUSAND)
TABLE 248. GERMANY APTAMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD THOUSAND)
TABLE 249. GERMANY APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD THOUSAND)
TABLE 250. GERMANY APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD THOUSAND)
TABLE 251. GERMANY APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2024 (USD THOUSAND)
TABLE 252. GERMANY APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2025-2030 (USD THOUSAND)
TABLE 253. GERMANY APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2024 (USD THOUSAND)
TABLE 254. GERMANY APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2025-2030 (USD THOUSAND)
TABLE 255. GERMANY APTAMERS MARKET SIZE, BY END-USER, 2018-2024 (USD THOUSAND)
TABLE 256. GERMANY APTAMERS MARKET SIZE, BY END-USER, 2025-2030 (USD THOUSAND)
TABLE 257. FRANCE APTAMERS MARKET SIZE, BY TYPE, 2018-2024 (USD THOUSAND)
TABLE 258. FRANCE APTAMERS MARKET SIZE, BY TYPE, 2025-2030 (USD THOUSAND)
TABLE 259. FRANCE APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2024 (USD THOUSAND)
TABLE 260. FRANCE APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2025-2030 (USD THOUSAND)
TABLE 261. FRANCE APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 262. FRANCE APTAMERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 263. FRANCE APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 264. FRANCE APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 265. FRANCE APTAMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD THOUSAND)
TABLE 266. FRANCE APTAMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD THOUSAND)
TABLE 267. FRANCE APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD THOUSAND)
TABLE 268. FRANCE APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD THOUSAND)
TABLE 269. FRANCE APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2024 (USD THOUSAND)
TABLE 270. FRANCE APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2025-2030 (USD THOUSAND)
TABLE 271. FRANCE APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2024 (USD THOUSAND)
TABLE 272. FRANCE APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2025-2030 (USD THOUSAND)
TABLE 273. FRANCE APTAMERS MARKET SIZE, BY END-USER, 2018-2024 (USD THOUSAND)
TABLE 274. FRANCE APTAMERS MARKET SIZE, BY END-USER, 2025-2030 (USD THOUSAND)
TABLE 275. RUSSIA APTAMERS MARKET SIZE, BY TYPE, 2018-2024 (USD THOUSAND)
TABLE 276. RUSSIA APTAMERS MARKET SIZE, BY TYPE, 2025-2030 (USD THOUSAND)
TABLE 277. RUSSIA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2024 (USD THOUSAND)
TABLE 278. RUSSIA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2025-2030 (USD THOUSAND)
TABLE 279. RUSSIA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 280. RUSSIA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 281. RUSSIA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 282. RUSSIA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 283. RUSSIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD THOUSAND)
TABLE 284. RUSSIA APTAMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD THOUSAND)
TABLE 285. RUSSIA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD THOUSAND)
TABLE 286. RUSSIA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD THOUSAND)
TABLE 287. RUSSIA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2024 (USD THOUSAND)
TABLE 288. RUSSIA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2025-2030 (USD THOUSAND)
TABLE 289. RUSSIA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2024 (USD THOUSAND)
TABLE 290. RUSSIA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2025-2030 (USD THOUSAND)
TABLE 291. RUSSIA APTAMERS MARKET SIZE, BY END-USER, 2018-2024 (USD THOUSAND)
TABLE 292. RUSSIA APTAMERS MARKET SIZE, BY END-USER, 2025-2030 (USD THOUSAND)
TABLE 293. ITALY APTAMERS MARKET SIZE, BY TYPE, 2018-2024 (USD THOUSAND)
TABLE 294. ITALY APTAMERS MARKET SIZE, BY TYPE, 2025-2030 (USD THOUSAND)
TABLE 295. ITALY APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2024 (USD THOUSAND)
TABLE 296. ITALY APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2025-2030 (USD THOUSAND)
TABLE 297. ITALY APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 298. ITALY APTAMERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 299. ITALY APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 300. ITALY APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 301. ITALY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD THOUSAND)
TABLE 302. ITALY APTAMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD THOUSAND)
TABLE 303. ITALY APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD THOUSAND)
TABLE 304. ITALY APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD THOUSAND)
TABLE 305. ITALY APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2024 (USD THOUSAND)
TABLE 306. ITALY APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2025-2030 (USD THOUSAND)
TABLE 307. ITALY APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2024 (USD THOUSAND)
TABLE 308. ITALY APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2025-2030 (USD THOUSAND)
TABLE 309. ITALY APTAMERS MARKET SIZE, BY END-USER, 2018-2024 (USD THOUSAND)
TABLE 310. ITALY APTAMERS MARKET SIZE, BY END-USER, 2025-2030 (USD THOUSAND)
TABLE 311. SPAIN APTAMERS MARKET SIZE, BY TYPE, 2018-2024 (USD THOUSAND)
TABLE 312. SPAIN APTAMERS MARKET SIZE, BY TYPE, 2025-2030 (USD THOUSAND)
TABLE 313. SPAIN APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2024 (USD THOUSAND)
TABLE 314. SPAIN APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2025-2030 (USD THOUSAND)
TABLE 315. SPAIN APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 316. SPAIN APTAMERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 317. SPAIN APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 318. SPAIN APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 319. SPAIN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD THOUSAND)
TABLE 320. SPAIN APTAMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD THOUSAND)
TABLE 321. SPAIN APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD THOUSAND)
TABLE 322. SPAIN APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD THOUSAND)
TABLE 323. SPAIN APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2024 (USD THOUSAND)
TABLE 324. SPAIN APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2025-2030 (USD THOUSAND)
TABLE 325. SPAIN APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2024 (USD THOUSAND)
TABLE 326. SPAIN APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2025-2030 (USD THOUSAND)
TABLE 327. SPAIN APTAMERS MARKET SIZE, BY END-USER, 2018-2024 (USD THOUSAND)
TABLE 328. SPAIN APTAMERS MARKET SIZE, BY END-USER, 2025-2030 (USD THOUSAND)
TABLE 329. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY TYPE, 2018-2024 (USD THOUSAND)
TABLE 330. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY TYPE, 2025-2030 (USD THOUSAND)
TABLE 331. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2024 (USD THOUSAND)
TABLE 332. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2025-2030 (USD THOUSAND)
TABLE 333. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 334. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 335. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 336. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 337. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD THOUSAND)
TABLE 338. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD THOUSAND)
TABLE 339. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD THOUSAND)
TABLE 340. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD THOUSAND)
TABLE 341. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2024 (USD THOUSAND)
TABLE 342. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2025-2030 (USD THOUSAND)
TABLE 343. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2024 (USD THOUSAND)
TABLE 344. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2025-2030 (USD THOUSAND)
TABLE 345. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY END-USER, 2018-2024 (USD THOUSAND)
TABLE 346. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY END-USER, 2025-2030 (USD THOUSAND)
TABLE 347. SAUDI ARABIA APTAMERS MARKET SIZE, BY TYPE, 2018-2024 (USD THOUSAND)
TABLE 348. SAUDI ARABIA APTAMERS MARKET SIZE, BY TYPE, 2025-2030 (USD THOUSAND)
TABLE 349. SAUDI ARABIA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2024 (USD THOUSAND)
TABLE 350. SAUDI ARABIA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2025-2030 (USD THOUSAND)
TABLE 351. SAUDI ARABIA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 352. SAUDI ARABIA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 353. SAUDI ARABIA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2024 (USD THOUSAND)
TABLE 354. SAUDI ARABIA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2025-2030 (USD THOUSAND)
TABLE 355. SAUDI ARABIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD THOUSAND)
TABLE 356. SAUDI ARABIA APTAMERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD THOUSAND)
TABLE 357. SAUDI ARABIA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD THOUSAND)
TABLE 358. SAUDI ARABIA APTAMERS MARKET SIZE, BY CLINICAL D

Samples

Loading
LOADING...

Companies Mentioned

  • 2bind GmbH
  • Agilent Technologies, Inc.
  • Aptadel Therapeutics SL
  • Aptagen, LLC
  • AptaMatrix, Inc.
  • Aptamer Group PLC
  • AptaTargets SL
  • AptusBiotech
  • Astellas Pharma Inc.
  • Base Pair Biotechnologies, Inc.
  • Basking Biosciences
  • Bio-Techne Corporation
  • Biogenes Technologies Sdn. Bhd.
  • Biotage
  • Cage Bio, Inc.
  • Creative Biogene
  • Creative Biolabs
  • Drive Therapeutics, LLC
  • F. Hoffmann-La Roche AG
  • Kaneka Eurogentec S.A.
  • NEC Corporation
  • NeoVentures Biotechnology Inc.
  • NOVAPTECH, S.A.S.
  • Profacgen
  • SomaLogic, Inc.
  • TAGCyx Biotechnologies, Inc.
  • Veraptus
  • Vivonics Inc.
  • Zentek Ltd.

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 285.51 Million
Forecasted Market Value ( USD ) by 2030 $ 513.77 Million
Compound Annual Growth Rate12.4%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Aptamers Market Report 2025 - Product Image

Aptamers Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Aptamers - Global Strategic Business Report - Product Image

Aptamers - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Aptamers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2031F - Product Image

Aptamers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2031F

  • Report
  • 188 Pages
  • Global
From
Aptamer Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Image

Aptamer Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • 93 Pages
  • Global
From
Aptamer Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Aptamer Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Market

The Aptamer market is a subset of the biotechnology industry that focuses on the development and production of aptamers, which are short, single-stranded DNA or RNA molecules that can bind to specific targets. Aptamers are used in a variety of applications, including diagnostics, therapeutics, and research. Aptamers are often used as alternatives to antibodies, as they are more stable, easier to produce, and can be tailored to bind to a wide range of targets. Aptamers are produced through a process called SELEX (Systematic Evolution of Ligands by Exponential Enrichment), which involves iterative cycles of selection and amplification of aptamers that bind to the desired target. This process is often automated, allowing for the rapid production of aptamers. The Aptamer market is growing rapidly, driven by increasing demand for aptamers in research and clinical applications. Companies in the Aptamer market include Aptagen, Aptamer Solutions, Base Pair Biotechnologies, and Aptamer Group. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.